Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.

Int J Cancer 2003 Aug;106(2):244-51

Kinderklinik, Hämatologie-Onkologie, Technische Universität, München, Germany.

Medulloblastoma is an embryonal childhood malignancy with poor prognosis. By screening 4 medulloblastoma cDNA expression libraries (SEREX) with autologous sera, 15 different antigens were identified. These antigens were encoded by 3 novel genes, genes of unknown function (KIAA0445, KIAA1853, KIAA0665, FLJ13942, HSPC213), a proto-oncogene (rab18), candidate tumor suppressor genes (BAP1, PRDM13) and genes encoding a motor protein (kinesin-2), a histone (H2A1.2), the ankyrin residue-rich nasopharyngeal cancer susceptibility protein (NZ16) and the transcription factor TZP, which is homologous to the tumor-associated antigens HCA58 and GLEA2. In a consecutive analysis of serum antibody titers and tumor load, a more than 10-fold increase in serum antibodies against PRDM13 preceded the clinical diagnosis of recurrent tumor growth in a patient with aggressive large cell medulloblastoma. When sera of pediatric patients with cancer (n = 40) and healthy controls (n = 40) were tested for humoral responses against the SEREX-defined antigens, 5 antigens were exclusively recognized by sera from cancer patients. These antigens included a novel rab18 gene product translated from mRNA sequences formerly described as 3' untranslated region. Humoral responses against 2 of the remaining 10 antigens were found preferentially in cancer patients. Antibodies against these antigens were detected in 8/40 and 12/40 cancer patients, respectively, but in only 1 healthy control. The 2 antigens were characterized by a tumor-specific deletion and a tumor-specific mutation, respectively. These findings indicate that the humoral immune response against medulloblastoma is directed against diverse antigens that may be useful as diagnostic markers or targets for immunotherapy.

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.11208
Publisher Site
http://dx.doi.org/10.1002/ijc.11208DOI Listing
August 2003
23 Reads

Publication Analysis

Top Keywords

cancer patients
12
antigens
11
antigens identified
8
humoral responses
8
medulloblastoma cdna
8
cancer
5
medulloblastoma
5
antibody titers
4
titers tumor
4
8/40 12/40
4
consecutive analysis
4
glea2 consecutive
4
12/40 cancer
4
tumor load
4
analysis serum
4
serum antibody
4
detected 8/40
4
prdm13 preceded
4
antigens detected
4
preceded clinical
4

References

(Supplied by CrossRef)
Strategies using the immune system for therapy of brain tumors
Virasch et al.
Neuro-oncology 2001
Brain tumors
Ashby et al.
Cancer Chemother Biol Response Modif 2001
Adoptive immunotherapy of CNS malignancies
Plautz et al.
Cancer Chemother Biol Response Modif 2001
Cancer genetics/epigenetics and the X chromosome: possible new links for malignant glioma pathogenesis and immune-based therapies
Mintz et al.
Crit Rev Oncol 2000
Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo
Okada et al.
Cancer Res 2001

Similar Publications